Imagine being able to study pathogen fitness and behavior in real-time
Now you can. By monitoring viral infections and bacterial biofilms continuously in an automated, non-invasive, and label-free manner the xCELLigence® Real-Time Cell Analysis (RTCA) instruments open up a whole new world of research possibilities.
Objective quantification: Subjective human observation of cytopathic effects are replaced with objective real-time data.
Reduced workload: No more plaque assays. Once cells are infected no further user involvement is required. Data is continuously recorded over assay windows spanning minutes to weeks.
Diverse applications: Viral titer determination, neutralizing antibody studies, drug screening, oncolytic viruses, etc.
Bacterial biofilm studies:
Continuous monitoring: Track biofilm formation and/or dissipation in real time to reveal behavioral details that are missed by end point assays.
Streamlined workflow: Seed cells and walk away. Staining, washing, and spectrophotometric analysis are eliminated. Data is continuously recorded for anywhere from minutes to days/weeks.
Remarkable flexibility: Quorum sensing, clinical theranostics, screening for biofilm preventing or disrupting compounds, multispecies co-culture, etc.
Learn more below:
Featured xCELLigence RTCA systems for infectious disease studies:
|Dual Purpose||Single Plate||Multi Plate||High Throughput|
|3×16 wells||1×96 wells||6×96 wells||Up to 4×384 wells|
|xCELLigence Research Grant|
The research grant winner will be provided access to the xCELLigence Real Time Cell Analysis (RTCA) DP instrument, consumables, and consultation for up to 6 months. Apply by December 8, 2018.